Etiology and treatment of periapical lesions around dental implants
Etiology
Different etiological factors play an important role in
the development and emergence of a periapical
implant lesion. As a retrograde peri-implantitis is
often accompanied by symptoms of pain, tenderness,
swelling and/or the presence of a fistulous tract, two
types of lesion can be distinguished: the diseaseactive periapical implant lesion; and the disease-inactive periapical implant lesion. Lesions are called
‘inactive’ when the radiological findings are not comparable with the clinical findings and/or the patient’s
symptoms. A clinically asymptomatic, periapical
radiolucency (which is usually caused by placement
of implants that are shorter than the prepared osteotomy) is to be considered as inactive When an
implant is placed next to a pre-existing, detectable
radiolucency, which is related to scar tissue, this also
can lead to an inactive lesion
. An inactive
lesion can also be caused by aseptic bone necrosis,
frequently induced by overheating the bone during
osteotomy preparation. Overheating is mentioned as
a risk factor for bone necrosis. This can eventually
compromise the primary stability of the dental
implant. Uncontrolled thermal injury can result in
the development of fibrous tissue, interpositioned at
the implant–bone interface, compromising the longterm prognosis of the implant.
An ‘active’ periapical implant lesion can be caused
by bacterial contamination
during insertion or by
premature loading leading to bone microfractures
before an adequate bone-to-implant interface has
been established. Implant insertion in a site with preexisting inflammation (caused by bacteria, viruses,
inflammatory cells and/or cells remaining from a cyst
or a granuloma) can also lead to an active periapical
implant lesion. These lesions are initiated at the apex
of the implant but have the capacity to spread coronally and facially. Furthermore, retrograde peri-implantitis should not be mistaken for nonintegration.
When, during placement, the apex of an implant
touches the tooth and/or when the implant is
inserted in an active endodontic lesion from an adjacent tooth, the implant may even exfoliate. Sussman
& Moss and Sussman described two basic
pathways of periapical implant pathology: type 1, the
implant-to-tooth pathway; and type 2, the tooth-toimplant pathway. In the type 1 pathway, the implantto-tooth lesion will develop when implant insertion
results in tooth devitalization (as a result of direct
trauma or indirect damage). This may occur when
the implant is placed at an insufficient distance from
a neighboring natural tooth or by overheating the
bone during osteotomy preparation. When the osteotomy causes direct trauma to the apex of a natural
tooth, it might destroy the blood supply to the pulp.
The resulting periapical tooth lesion will contaminate
the implant . In the type 2 pathway, the
lesion will occur quite shortly after implant insertion
when an adjacent tooth develops a periapical pathology (caries involvement, external root resorption
, reactivation of a previously existing apical lesion
or the removal of an endodontic seal
The majority of authors consider an endodontic
pathology of the natural tooth at the site of the
implant (or an adjacent tooth) to be the most likely
cause for periapical implant pathology
Ayangco & Sheridan published a series of case
reports in which oral implants were placed in sites
where previous tooth root apical surgery failure had
occurred. They reported that, even with thorough
curettage of the sockets and a prolonged healing time
before implant placement, bacteria have the capacity
to remain in the bone and may cause lesions on the
subsequent inserted implants. Brisman et al.
reported that even asymptomatic endodontically
treated teeth with a normal periapical radiographic
appearance could be the cause of an implant failure.
They also suggested that microorganisms may persist,
even though the endodontic treatment is considered
radiographically successful, because of inadequate
obturation or an incomplete seal.
Lefever et al. examined the periapical status of the
extracted tooth at the implant site and the adjacent
teeth before implant placement .
The periapical
status of the tooth at the implant site and the adjacent teeth before extraction was explored and identi-
fied as: no endodontic treatment and no periapical
lesion; a periapical lesion at the root combined with
or without an endodontic treatment; and an endodontic treatment without clear signs of a periapical
lesion. If the extracted tooth showed no signs of a
periapical lesion and had no endodontic treatment,
the incidence of apical pathology was 2.1%. On the
other hand, if an endodontic treatment or a periapical lesion at the apex of the tooth was present at the
moment of extraction, a periapical lesion could be
found around the implant in 8.2% and 13.6% of the
cases, respectively. For teeth extracted without endodontic pathology, the adjacent teeth might have an
effect on the future implant. If the adjacent teeth, on
either the mesial or the distal side, showed no signs
of pathology or did not receive endodontic treatment, only 1.2% of the implants presented with a
periapical lesion. When an endodontic treatment
had been performed previously, but no signs of periapical pathology could be detected, no periapical
lesions around the implants could be found. However, if there were signs of periapical pathology at
the neighboring teeth, 25% of the implants also
showed a periapical lesion .
When the proper protocols are followed it has been
shown that immediate implant placement into fresh
extraction sockets is a valuable treatment strategy
. The most clinically predictable method of
addressing the immediate placement of implants in a
fresh extraction socket containing apical pathology is
obtaining access in conjunction with thorough
debridement of all pathologic tissues. Adjunctive
antibiotic therapy, both local and systemic, is highly
recommended. Before the debridement of infected
apical tissues, bacterial cultures should be obtained
to inform the clinician if a specific antibiotic therapy
is required. However, immediate implant placement
in infected sites remains a topic of discussion. Several
authors have considered immediate implant placement in infected sites as a contraindication
because these sites may compromise an uneventful osseointegration and may result in the development of an implant periapical lesion .
Alsaadi et al. reported a greater tendency for
implant failure in sites with apical pathology.
Crespi et al.
placed 15 implants immediately in
periapical infected sites and 15 in noninfected sites.
At the 12- month follow-up they recorded no difference in integration, hard and soft tissue conditions at
both types of sites. Lindeboom et al. placed 50
implants in chronic periapical infected sites. Twenty-
five were placed immediately after extraction and
were placed after a mean healing period of 3 months.
They reported a survival rate of 92% for the immediately placed implants compared with 100% in the
control group. Furthermore, mean implant stability
quotient values, gingival esthetics, radiographic bone
loss and microbiological characteristics were not significantly different. They concluded that immediate
placement of implants into chronically infected periapical sites may be a valuable treatment option. Fu
gazzotto conducted a retrospective analysis of
418 immediately placed implants in sites showing
periapical pathology. The cumulative survival rates in
this study were similar to those for immediately
placed implants in sites showing no periapical pathology. In a recent study by Jung et al. , the immediate placement of implants in sites with periapical
pathology was compared with immediate placement
in healthy sites. The implants were followed during a
5-year period. They concluded that the replacement
of teeth exhibiting periapical pathologies with
implants placed immediately after tooth extraction
can be a successful treatment modality with no disadvantages in clinical, esthetic and radiologic parameters compared with immediate placement of implants
in healthy sockets.
Even though most authors consider a microbiological factor important in the pathogenesis of an active
periapical implant lesion, convincing data remain
very scarce. Romanos et al. conducted a histologic investigation of 32 implants with periapical
infection. Bacteria were found in only one case. Chan
et al. reported the presence of Eikenella corrodens in a surgically treated periapical lesion. Lefever
et al.
took a microbial sample of 21 periapical
implant lesions at the moment of treatment. These
samples were analysed for Enterococcus species, Aggregatibacter actinomycetemcomitans, Campylobacter
rectus, Fusobacterium nucleatum, Prevotella intermedia and Porphyromonas gingivalis. Also, the total
counts of aerobic and anaerobic bacteria were analyzed. Bacteria were found in nearly all sites, but only
at a concentration of ≥log 4 in nine of 21 sites. The
proportion of anaerobic species was always higher
than that of aerobic species. Porphyromonas gingivalis and P. intermedia were detected in reasonable
concentrations at six and four sites, respectively. The
other specific species (A. actinomycetemcomitans,
C. rectus, F. nucleatum and Enterococcus species)
never reached the threshold level for identification.
Further factors related to implant periapical pathology are: the presence of residual root fragments or
foreign bodies; placement of an oral implant
in the proximity of an infected maxillary sinus;
placement of the implant in the nasal cavity ; and
excessive tightening of the implant during insertion
causing compression of the bone , although there
is no way of ascertaining the degree of compression
at the apex of the implant, even if insertion torques
are higher than normal. The etiopathogenesis of an
active periapical implant lesion remains controversial
and it is believed to have a multifactorial pathogenesis
Diagnosis
The diagnosis of an implant periapical lesion is based
on both clinical and radiological findings. As mentioned above, these lesions are classified into two
groups: the inactive and the active forms. The inactive
lesions are asymptomatic and are radiologically
found as a result of the presence of radiolucency
around the apex of the implant. These lesions do not
need further treatment, although they should be followed radiologically on a regular basis, as an increase
in size of the radiolucency may indicate activation
and the need for further treatment. Active lesions are
frequently (but not necessarily) clinically symptomatic. Clinical findings may comprise constant and
intense pain (persisting even after analgesic treatment) , inflammation , dull percussion, the
presence of a fistulous tract and the presence
of mobility. If pain is present, this will not increase
after implant percussion because the bone–implant
interface is direct. Because there is no pressure to create a fistulous tract, and purulent materials can
emerge through the still not fully consolidated interface between implant and bone, this clinical finding
is not always present . According to Pe
~
narrochaDiago et al.
, the diagnosis must include determination of the evolution stage of the lesion in order to
apply the best treatment strategy. The authors divide
the evolution of the periapical implant lesion into
three parts:
Part 1. The nonsuppurated acute periapical
implant lesion: an acute inflammatory infiltrate is
detectable and clinically characterized by the
presence of acute spontaneous and localized pain
that does not increase with percussion. The
mucosa can be swollen and sometimes painful.
Percussion of the implant will produce a tympanic
sound. Radiographically, there are no changes in
bone density around the apex of the implant.
Part 2. The suppurated acute periapical implant
lesion: a purulent collection is formed around the
apex of the implant. This collection will result in
bone resorption as it searches for a pathway for
drainage. When this pathway has been established, the next stage is reached. Clinical signs are
comparable with the nonsuppurated stage. Radiographically, however, a radiolucency can be
detected around the apex of the implant.
Part 3. The suppurated-fistulized periapical
implant lesion: when the bone-to-implant junction is established in the coronal part a fistulous
tract can develop from the apex of the implant
through the cortex of the buccal plate. If the coronal junction is not established, the peri-implant
bone will also be destroyed in a coronal direction
and eventually this will lead to implant loss. Clinical signs are various. Radiographically, bone
resorption around the implant can be seen.
Care should be taken because two-dimensional
periapical radiographs do not always show the actual
size of an intrabony defect. Only when the junctional
area is involved, can these kinds of defects be identi-
fied. Therefore, it might be possible that some periapical pathologies are not recognized on twodimensional radiographs, which is a limiting factor in
the diagnosis . Cone beam computed tomography
can be used to overcome this limitation.
Prevalance
The prevalence of periapical implant pathology is fortunately rather low. Quirynen et al. reported a
prevalence of periapical implant pathology of 1.6% in
the maxilla and 2.7% in the mandible in a retrospective study on 539 implants.
On a study of 3800 implants, Reiser & Nevins
found a prevalence of periapical implant pathology of
0.3%. According to a recent study by Lefever et al.
a periapical lesion around the implant can be
detected in 8.2% of implants, which increases up to
13.6% if an endodontic treatment or a periapical
lesion at the apex of a previously extracted tooth is
present. For periapical pathology at the adjacent
teeth, the percentage rises to 25%.
Treatment
Penarrocha-Diago et al. and Zhou et al. consider the correct and an early diagnosis of periapical
implant lesions as a prerequisite for the prevention of
implant failure. As periapical lesions around dental
implants are considered to have a multifactorial etiology, there is no consensus regarding the therapy. A
search of the literature leads to predominantly case
reports of possible treatment options.
In some case reports, nonsurgical treatments are
discussed. Chang et al. treated one patient without surgical intervention. They used amoxicillin in
combination with clavulanic acid, prednisolone and
mefenamic acid, after which the patient’s symptoms
completely subsided and radiographically the lesion
disappeared. After a follow-up of 2 years the implant
remained stable. Waasdrop & Reynolds also treated one patient nonsurgically with the use of antibiotics. The radiographic lesion gradually resolved during
the following 9 months without further treatment.
However, other authors reported that antibiotics were
not effective in controlling active lesions
So
the question arises of whether the healing of periapical implant lesions in the previously mentioned studies was caused by treatment with the prescribed
drugs or whether these lesions were inactive.
In order to prevent osteomyelitis, and because
retaining the implant can lead to further and irreversible bone loss, some authors advised an early
explantation of the infected implant(s) ,
. However, most authors agree that the apex of
the implant should be surgically exposed. How the
therapy should be continued after exposure remains
a topic of discussion. Reiser & Nevins and Oh
et al. propose elimination of the infection and
an implant apical resection or implant removal,
depending on the extent of the infection and the stability of the implant. Zhou et al. treated six
implants in six patients, showing periapical pathology through trepanation and curettage (without
resection of the apical part and the use of a bonesubstitute material). The lesions were copiously irrigated with saline and chlorhexidine solution and the
residual bone defects were further treated with tetracycline paste. Radiographically, the lesion disappeared and the implants were normally loaded after
3 months. The irrigation agents used most often for
decontamination of the implant surface are saline
solution , chlorhexidine solution
or tetracycline pastes . Whether any of these
agents are efficient in decontaminating the implant
surface remains questionable.
Some authors report on the use of bone substitutes,
with or without the use of membranes, to achieve a
complete resolution of the bony defect. Quirynen
et al. performed treatment on 10 cases with periapical implant pathology (out of a total of 426 solitary
implants). The protocol for the treatment (Fig. 1) of
retrograde lesions in the maxilla included elevation of
a full-thickness flap, complete removal of all accessible granulation tissue using hand instruments (with
special attention to reach both apical and oral parts
of the implant surface) and curettage of the bony cavity walls. In half of the defects, deproteinized bovine
bone mineral was used as bone substitute (at the discretion of the surgeon), whereas the other defects
were left empty. In the mandible an explorative flap
mostly revealed an absence of a perforation of the
cortex so that a trepanation of the bone had to be
performed. They concluded that the removal of
all granulation tissue is sufficient to arrest the
progression of bone destruction. Furthermore,
implants in which only the coronal part is osseointegrated can successfully resist occlusal load for years,
at least in the single-tooth replacement condition.
Bretz et al. surgically treated one case of periapical implant pathology via the elevation of a full-thickness flap, curettage of the apical lesion, irrigation
with chlorhexidine gluconate, placement of demineralized freeze-dried bone and coverage of the site with
an resorbable collagen membrane. The lesion was
resolved and the prosthesis was still in function after
17 months of follow-up. Lefever et al. retrospectively analysed 59 implants with periapical lesions.
Different treatment options were chosen: explantation of the affected implant curettage of the
defect and application of a bone substitute
curettage and administration of systemic antibiotics
; curettage only ; no treatment (two of
; systemic antibiotics without curettage (two of
curettage with the usage of a barrier membrane
without application of a bone substitute (two of 59);
and curettage and application of autogenous bone
chips . Of the 42 nonexplanted implants,
nine were lost during follow-up, all during the first
4 years of loading. The cumulative survival rate for an
implant showing a periapical lesion was 46.0%. When
the explanted implants were excluded, the cumulative survival rate reached 73.2% after 10 years. The
authors conclude that a clear-cut selection of ‘best
treatment strategy’ could not be identified. Balshi
et al. (7) suggested apical resection of the affected
implants. They used this approach on 39 cases. After
flap elevation, they used a high-speed drill to create a
bony window that was slightly larger than the lesion
itself. The bony defect was thoroughly debrided and
irrigated with a saline/tetracycline soluti